AzTrials
AzTrials

Anxiety and FearNCT04406181

Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic

A study testing HADS and a survey in people with Anxiety and Fear and Anxiety Depression, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The effect and impact of postponing cardiac surgery / creating a waiting list as a result of COVID-19 on patients, both psychologically and symptomatically on three groups of patients: 1. The degree of anxiety and/or depression induced by their altered medical care trajectory. 2. Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
HADS and a survey
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteBelgium
Study dates
18 May 2020to 1 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All adult patients whose operation date has been deferred due to the pandemic COVID-19.
  • All patients who did not have had an operation date before the pandemic COVID-19.
  • All patients who have been operating on during the month before the pandemic COVID-19.

Who cannot join

  • N/A

Trial locations and contacts

1 site in 1 country.

Veerle Van Mossevelde, Data Nurse contact

+3224763134

veerle.vanmossevelde@uzbrussel.be

Belgium1 site, 1 recruiting
  • universitair Ziekenhuis Brussel

    Jette, Vlaams Brabant, 1090

    Veerle Van Mossevelde, +3224763134, veerle.vanmossevelde@uzbrussel.be

    Recruiting

Other trials in Belgium

About this study

Official title: Effect on the COVID-19 Pandemic-induced Reduction in Elective Surgery on Medical Events and Psychological Well-being of Patients Waiting for Cardiac Surgery

The effect and impact of postponing cardiac surgery / creating a waiting list as a result of COVID-19 on patients, both psychologically and symptomatically on three groups of patients:

  1. The degree of anxiety and/or depression induced by their altered medical care trajectory.
  2. The incidence of medical problems induced by deferred elective surgery or delayed postoperative ambulatory visit
  3. The occurrence of reduced access to medical and psychological help
Read the detailed description

A prospective study by means of a questionnaire, specifically designed for each of the three groups.

  1. Adult patients whose operation date has been deferred
  2. Patients who did not have had an operation date
  3. Patients who have been operating on during the month before

Each group will receive a twofold questionnaire:

Part I: Hospital Anxiety and Depression Scale (HADS), a robust questionnaire used for hospitalized and non-hospitalized patients gauging the degree of anxiety and/or depression, irrespective of their specific medical condition. All three groups receive the same list of questions.

-Part II: a questionnaire made up specifically for issues concerning the medical/psychological/access aspects during the COVID-19 outbreak. Each of the three groups will receive a questionnaire, adapted to the group they are assigned to.

The questionnaires will be delivered by the use of Qualtrics or on paper. Timing and mode of presentation (Qualtrics or fill-in paper on admission) of the questionnaire will depend on the length of the quarantine measures.

Being tested
HADS, a survey
Keywords
cardiac surgery, postoperative consultation, postponed elective surgery, COVID-19
Medical subject headings
Anxiety Disorders, Stress, Psychological, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HADSBehavioural

    Also called questionnaire

    Hospital Anxiety and Depression Scale

  • a surveyBehavioural

    made up specifically for issues concerning the medical/psychological/access aspects during the COVID-19 outbreak

Study groups in NCT04406181
Study groupRoleWhat they receive
operation deferredOtherAdult patients whose operation date has been deferred due to the pandemic
Receives: Behavioral: HADS; Behavioral: a survey
no operation dateOtherPatients who did not have had an operation date and who were told to need cardiac surgery before the pandemic started
Receives: Behavioral: HADS; Behavioral: a survey
postoperative consultation deferredOtherPatients who have been operating on during the month before the pandemic
Receives: Behavioral: HADS; Behavioral: a survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety/depression by means of Hospital Anxiety and Depression Scale (HADS)

    The degree of anxiety and/or depression in all three groups, induced by their altered medical care trajectory. 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)

    Measured: 10 minutes

  2. Medical problems induced by deferred elective surgery or delayed postoperative ambulatory visit

    The incidence of medical problems induced by deferred elective surgery or delayed postoperative ambulatory visit by means of an adjusted survey.

    Measured: 10 minutes

  3. Reduced access to medical and psychological help

    The occurrence of reduced access to medical and psychological help by means of an adjusted survey.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2020
  2. Study start18 May 2020
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion1 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04406181
Sponsor's protocol ID
COVID-19 Cardiac psy wellbeing
Status last verified
May 2020
First submitted
28 Apr 2020
Last updated
1 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HADS and a survey in people with Anxiety and Fear and Anxiety Depression, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Veerle Van Mossevelde, Data Nurse (+3224763134, veerle.vanmossevelde@uzbrussel.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety/depression by means of Hospital Anxiety and Depression Scale (HADS) (time frame: 10 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in